tradingkey.logo

GeneDx Holdings Corp

WGS
136.910USD
+5.410+4.11%
Cierre 10/31, 16:00ETCotizaciones retrasadas 15 min
3.96BCap. mercado
1898.84P/E TTM

GeneDx Holdings Corp

136.910
+5.410+4.11%

Más Datos de GeneDx Holdings Corp Compañía

GeneDx Holdings Corp. is a genomics company. The Company is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company's segments are GeneDx inclusive of Legacy GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. GeneDx utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. GeneDx provides a variety of genetic diagnostic tests, screening solutions, and information. The Legacy Sema4 diagnostics segment provides reproductive and women's health and somatic oncology diagnostic testing and screening products.

Información de GeneDx Holdings Corp

Símbolo de cotizaciónWGS
Nombre de la empresaGeneDx Holdings Corp
Fecha de salida a bolsaSep 04, 2020
Director ejecutivoMs. Katherine A. Stueland
Número de empleados1000
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 04
Dirección333 Ludlow Street
CiudadSTAMFORD
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal06902
Teléfono18887291206
Sitio Webhttps://sema4.com/
Símbolo de cotizaciónWGS
Fecha de salida a bolsaSep 04, 2020
Director ejecutivoMs. Katherine A. Stueland

Ejecutivos de GeneDx Holdings Corp

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+6.12%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+63.87%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
3.75K
-8.86%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
3.58K
-82.23%
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+6.12%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+63.87%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
3.75K
-8.86%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
3.58K
-82.23%
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Patients with third party insurance
81.10M
78.98%
Institutional customers
18.38M
17.90%
Other
2.87M
2.79%
Self pay patients
339.00K
0.33%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Patients with third party insurance
81.10M
78.98%
Institutional customers
18.38M
17.90%
Other
2.87M
2.79%
Self pay patients
339.00K
0.33%

Estadísticas de accionistas

Actualizado: vie., 31 de oct
Actualizado: vie., 31 de oct
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Corvex Management LP
10.58%
Casdin Capital, LLC
10.54%
William Blair Investment Management, LLC
5.64%
Icahn School of Medicine at Mount Sinai
4.75%
OPKO Health Inc
4.74%
Otro
63.74%
Accionistas
Accionistas
Proporción
Corvex Management LP
10.58%
Casdin Capital, LLC
10.54%
William Blair Investment Management, LLC
5.64%
Icahn School of Medicine at Mount Sinai
4.75%
OPKO Health Inc
4.74%
Otro
63.74%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
36.63%
Hedge Fund
36.17%
Investment Advisor
31.04%
Corporation
10.65%
Research Firm
6.54%
Individual Investor
1.61%
Pension Fund
0.81%
Venture Capital
0.54%
Bank and Trust
0.48%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
427
31.75M
110.52%
-296.44K
2025Q2
397
34.23M
119.24%
+1.02M
2025Q1
398
32.79M
115.46%
-47.86K
2024Q4
341
29.17M
104.22%
+1.72M
2024Q3
289
26.18M
97.50%
+377.48K
2024Q2
262
24.98M
95.33%
+588.25K
2024Q1
260
22.13M
86.19%
+1.41M
2023Q4
271
20.57M
80.67%
-567.28K
2023Q3
283
21.68M
85.29%
-751.02K
2023Q2
291
21.85M
86.03%
-864.88K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Corvex Management LP
3.06M
10.65%
--
--
Aug 22, 2025
Casdin Capital, LLC
3.05M
10.6%
-461.51K
-13.16%
Aug 22, 2025
William Blair Investment Management, LLC
1.63M
5.68%
+442.41K
+37.21%
Jun 30, 2025
Icahn School of Medicine at Mount Sinai
1.37M
4.78%
-1.35M
-49.50%
Feb 21, 2025
OPKO Health Inc
1.37M
4.77%
-800.83K
-36.88%
Nov 20, 2024
BlackRock Institutional Trust Company, N.A.
1.28M
4.45%
+241.28K
+23.25%
Jun 30, 2025
Pentwater Capital Management LP
1.22M
4.25%
+1.19M
+3712.50%
Jun 30, 2025
The Vanguard Group, Inc.
1.18M
4.09%
+148.96K
+14.50%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
1.04M
3.61%
+533.38K
+105.89%
Jun 30, 2025
UBS Financial Services, Inc.
1.00M
3.49%
+951.52K
+1895.62%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: lun., 6 de oct
Actualizado: lun., 6 de oct
Nombre
Proporción
Global X Genomics & Biotechnology ETF
3.85%
SPDR S&P Health Care Services ETF
3.59%
Innovator IBD 50 Fund ETF
3.05%
Alger Mid Cap 40 ETF
2.05%
Harbor Health Care ETF
2.05%
Simplify Health Care ETF
1.32%
Franklin Genomic Advancements ETF
1.23%
Main Thematic Innovation ETF
1.02%
Hypatia Women CEO ETF
0.87%
ARK Genomic Revolution ETF
0.83%
Ver más
Global X Genomics & Biotechnology ETF
Proporción3.85%
SPDR S&P Health Care Services ETF
Proporción3.59%
Innovator IBD 50 Fund ETF
Proporción3.05%
Alger Mid Cap 40 ETF
Proporción2.05%
Harbor Health Care ETF
Proporción2.05%
Simplify Health Care ETF
Proporción1.32%
Franklin Genomic Advancements ETF
Proporción1.23%
Main Thematic Innovation ETF
Proporción1.02%
Hypatia Women CEO ETF
Proporción0.87%
ARK Genomic Revolution ETF
Proporción0.83%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Fecha
Tipo
Relación
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
KeyAI